Bone Resorption, Osteoclastogenesis and Adalimumab
Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
Broca II is the prolongation of the original study name BROCA. In BROCA study, only 25
patients participated and it was not enough to concluded clearly our hypothesis.